GR3004966T3 - - Google Patents

Info

Publication number
GR3004966T3
GR3004966T3 GR920401300T GR920401300T GR3004966T3 GR 3004966 T3 GR3004966 T3 GR 3004966T3 GR 920401300 T GR920401300 T GR 920401300T GR 920401300 T GR920401300 T GR 920401300T GR 3004966 T3 GR3004966 T3 GR 3004966T3
Authority
GR
Greece
Prior art keywords
agent
colestyramin
endowed
pharmaceutical composition
active principle
Prior art date
Application number
GR920401300T
Other languages
Greek (el)
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3004966T3 publication Critical patent/GR3004966T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GR920401300T 1986-06-16 1992-06-18 GR3004966T3 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT20799/86A IT1190349B (it) 1986-06-16 1986-06-16 Composizioni farmaceutiche ad attivita' sequestrante degli acidi biliari contenenti colestiramina quale principio attivo,e procedimento per prepararle

Publications (1)

Publication Number Publication Date
GR3004966T3 true GR3004966T3 (enExample) 1993-04-28

Family

ID=11172237

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920401300T GR3004966T3 (enExample) 1986-06-16 1992-06-18

Country Status (8)

Country Link
US (1) US4902501A (enExample)
EP (1) EP0251369B1 (enExample)
JP (1) JPS62298533A (enExample)
AT (1) ATE76297T1 (enExample)
DE (1) DE3779189D1 (enExample)
ES (1) ES2044912T3 (enExample)
GR (1) GR3004966T3 (enExample)
IT (1) IT1190349B (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3808191C2 (de) * 1988-03-11 1998-08-06 Astra Chem Gmbh Colestyramin enthaltende pharmazeutische Zusammensetzung
DE68907721T2 (de) * 1988-06-24 1993-11-18 Upjohn Co Feingemahlenes colestipol-hydrochlorid.
EP0447362A1 (en) * 1990-03-13 1991-09-18 Warner-Lambert Company Improved ingestible anion exchange resin delivery system compositions containing adipic acid
US5091175A (en) * 1990-05-14 1992-02-25 Erbamont Inc. Pharmaceutical composition containing bile acid sequestrant enclosed in a size-exclusion membrane
US5137716A (en) * 1990-11-15 1992-08-11 Weisenfeld Michael S Method of reducing weight in mammals
US5830452A (en) * 1990-11-20 1998-11-03 Chiron Corporation Method for enhancing the anti-tumor therapeutic index of interleukin-2
CA2042870C (en) * 1991-05-17 1996-11-26 Leon Edward St. Pierre Metal ion coordinated polyamine resins for the lowering of blood cholesterol
IT1306171B1 (it) * 1999-07-21 2001-05-30 Wiktor Djaczenko Composizione farmaceutica a base di c2 hcl3o2, un polimero h (och2ch2)6oh, acido 2-idrossibenzoico, (1alfa, 2beta, 5alfa) -5-metil-2-
US7527807B2 (en) * 2000-06-21 2009-05-05 Cubist Pharmaceuticals, Inc. Compositions and methods for increasing the oral absorption of antimicrobials
BR0112800A (pt) * 2000-07-28 2003-07-01 Hoffmann La Roche Utilização de um inibidor de lìpases e de um sequestrante de ácido de bìlis farmaceuticamente aceitáveis e processo para a prevenção e tratamento de enfermidades associadas com altos nìveis de colesterol de plasma
CN100423715C (zh) * 2000-07-28 2008-10-08 霍夫曼-拉罗奇有限公司 新型药物组合物
US7459502B2 (en) * 2003-11-03 2008-12-02 Ilypsa, Inc. Pharmaceutical compositions comprising crosslinked polyamine polymers
US7449605B2 (en) * 2003-11-03 2008-11-11 Ilypsa, Inc. Crosslinked amine polymers
US7767768B2 (en) * 2003-11-03 2010-08-03 Ilypsa, Inc. Crosslinked amine polymers
US7608674B2 (en) * 2003-11-03 2009-10-27 Ilypsa, Inc. Pharmaceutical compositions comprising cross-linked small molecule amine polymers
US7335795B2 (en) 2004-03-22 2008-02-26 Ilypsa, Inc. Crosslinked amine polymers
US7385012B2 (en) * 2003-11-03 2008-06-10 Ilypsa, Inc. Polyamine polymers
CA2557999C (en) 2004-03-30 2013-11-12 Ilypsa, Inc. Methods and compositions for treatment of ion imbalances
US7429394B2 (en) * 2004-03-30 2008-09-30 Relypsa, Inc. Ion binding compositions
US7556799B2 (en) 2004-03-30 2009-07-07 Relypsa, Inc. Ion binding polymers and uses thereof
US7854924B2 (en) * 2004-03-30 2010-12-21 Relypsa, Inc. Methods and compositions for treatment of ion imbalances
US8282960B2 (en) * 2004-03-30 2012-10-09 Relypsa, Inc. Ion binding compositions
US8192758B2 (en) * 2004-03-30 2012-06-05 Relypsa, Inc. Ion binding compositions
CA2606386C (en) * 2005-04-29 2014-06-10 Cubist Pharmaceuticals, Inc. Therapeutic compositions
CA2622693C (en) 2005-09-15 2015-05-05 Genzyme Corporation Sachet formulation for amine polymers
AU2006299449B2 (en) 2005-09-30 2013-07-04 Relypsa, Inc. Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal
JP2009510233A (ja) * 2005-09-30 2009-03-12 レリプサ， インコーポレイテッド 架橋シェルを有するコア−シェルコンポジットを製造する方法および該方法によって生じたコア−シェルコンポジット
US20100104527A1 (en) * 2008-08-22 2010-04-29 Relypsa, Inc. Treating hyperkalemia with crosslinked cation exchange polymers of improved physical properties
WO2010022380A2 (en) 2008-08-22 2010-02-25 Relypsa, Inc. Linear polyol stabilized polyfluoroacrylate compositions
EP3431094B1 (en) * 2008-08-22 2022-12-07 Vifor (International) Ltd. Crosslinked cation exchange polymers, compositions and use in treating hyperkalemia
CN104822383A (zh) 2012-10-08 2015-08-05 瑞立普萨公司 治疗高血压和高血钾症的钾结合剂
US9345741B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
US9345727B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US10245284B2 (en) 2015-08-19 2019-04-02 Alpex Pharma S.A. Granular composition for oral administration

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2838440A (en) * 1953-10-29 1958-06-10 Rohm & Haas Dusting powder of carboxylic cationexchange resin and powder base
NL7017227A (enExample) * 1969-12-27 1971-06-29
NL7311319A (enExample) * 1972-09-01 1974-03-05
GB1566609A (en) * 1977-03-10 1980-05-08 Reckitt & Colmann Prod Ltd Pharmaceutical compositions containing cholestyramine and alginic acid
IT1106718B (it) * 1978-12-21 1985-11-18 Alfa Farmaceutici Spa Composizioni a base di resine anioniche salificate farmacologicamente attive
BE896241A (fr) * 1983-03-22 1983-07-18 Prosan Internat Composition antidiarrheique a usage veterinaire et methode d'utilisation de cette composition

Also Published As

Publication number Publication date
ATE76297T1 (de) 1992-06-15
IT1190349B (it) 1988-02-16
US4902501A (en) 1990-02-20
IT8620799A0 (it) 1986-06-16
DE3779189D1 (de) 1992-06-25
EP0251369A2 (en) 1988-01-07
JPS62298533A (ja) 1987-12-25
EP0251369A3 (en) 1988-05-11
ES2044912T3 (es) 1994-01-16
EP0251369B1 (en) 1992-05-20
IT8620799A1 (it) 1987-12-16

Similar Documents

Publication Publication Date Title
EP0251369A3 (en) Pharmaceutical compositions endowed with sequestering activity for the biliary acids, containing colestyramin as their active principle, and process for preparing them
IL96400A0 (en) Herbicidal compositions containing an imizapyr analog together with another active agent
CZ8193A3 (en) Pharmaceutical dosing form with prolonged release of active compound
NZ231508A (en) Hydroxamic acid derivatives, pharmaceutical compositions and intermediate compounds
GR3006177T3 (enExample)
PH30439A (en) 3,4-Dihydro-2h-1,4-benz-oxazine derivatives and pharmaceutical compositions containing the same
IT1237485B (it) Composizione avente attivita' battericida oppure batteriostatica.
ZA90946B (en) Medicament containing dihydrolipoic acid as active substance
HUT41765A (en) Herbicide composition containing 5-amino-1-pyridyl-pyrazole derivatives and process for producing the active agents
EP0440809A4 (en) Methylenediphosphonic acid compound and anti-inflammatory containing the same as active ingredient
HUT41957A (en) Insecticide compositions containing aryl-pyridon derivatives as active agents and process for producing the active agents
IL91047A0 (en) Pharmaceutical compositions containing a zinc complex
IL80900A0 (en) Pharmaceutical composition for treatment of thrombosis containing fibrinolytic compounds and prostacyclin derivatives
IL90551A0 (en) Stable,injectable,aqueous pharmaceutical compositions for the treatment of cardiac conditions
ZA906383B (en) Long active injectable formulations containing triacetin
HUT41206A (en) Fungicide compositions containing alpha-oximino-alpha-carbamoyl-acetonitril derivatives as active agents and process for producing the active agents
HUT41784A (en) Process for producing 1,8-naphtiridine derivatives and pharmaceutical compositions containing them as active agents
HUT41230A (en) Pesticide compositions containing substituted 4,5-dihydro-1,3,4-thiadiazol derivatives as active agents and process for producing the active agents
HUT41764A (en) Herbicide compositions containing 5-amino-4-cyano-1-pyridyl-pyrazole derivatives as active agents and process for producing the active agents
EP0495106A4 (en) Osteogenesis promoter
HUT41376A (en) Insecticide compositions containing phenyl-hidrazine derivatives as active agents and process for producing the active agents
HUT43232A (en) Herbicide compositions containing 2-square bracket-bracket-heterocyclic-oxy-bracket closed-phenoxy-square bracket closed-alkanoyl-bracket-halogeno-alkoxy-bracket closed-anilide derivatives as active agents and process for producing the active agents
HUT41757A (en) Process for producing pharmaceutical compositions containing e-desmethyl-mevalonic acid derivatives and process for producing the active agents
HUT41965A (en) Insecticide compositions containing s,s-di/terc-alkyl/-thiophosphonate derivatives as active agents and process for producing the active agents
MX9707695A (es) Empaque que contiene una formulacion de solucion acuosa de clorhidrato de procaterol, y una formulacion de solucion acuosa de clorhidrato de procaterol.